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Retinal degenerations and dystrophies are the major causes of genetically inherited blindness that are characterized by the apoptotic
death of the photoreceptor cell layer of the retina. To date, no treatment exists for these diseases and only recently have they been
considered as candidates for gene and stem cell therapies. Here we report the ability of adult CD90marrow stromal cells (MSCs) to be
induced by activin A, taurine, and EGF into cells (20 –32%) expressing photoreceptor-specific markers rhodopsin, opsin, and recoverin
in vitro. CD90 cells were either transduced with recombinant adeno-associated virus expressing green fluorescent protein (GFP) or
bromodeoxyuridine (BrdU) labeled and then injected into the subretinal space of adult Royal College of Surgeons rats. Fundus photog-
raphy and angiography showed no adverse effects of CD90 MSC transplantation. GFP-expressing cells or BrdU-positive cells covered
30% of the entire retinal area. By 2 weeks after injection, CD90MSCs integrated into the host retina, forming structures similar to the
photoreceptor layer and expressed a photoreceptor-specific marker. No teratoma formation was observed in the recipient retina. The
subretinally delivered CD90MSCs did not stain for proliferating cell nuclear antigen, indicating that they primarily undergo differen-
tiation rather than proliferation. In addition, we established that transplanted cells can attract synaptic vesicles and hence are potentially
capable of signal transduction. This study demonstrates for the first time the partial differentiation of adult CD90MSCs into photore-
ceptors in vitro and in vivo. Our results establish a proof of concept for CD90 MSC differentiation with autologous transplantation,
which may provide a promising therapeutic strategy for the treatment of some forms of genetically inherited retinal degenerations.
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Introduction
Retinal degenerations and dystrophies are the major causes of
genetically inherited blindness in the developed world. These
conditions are typically characterized by the apoptotic death of
one of a subset of cells in the retina, namely the photoreceptors
(Gavrieli et al., 1992; Lolley et al., 1994). Because visually evoked
responses have been recorded in animals suffering degeneration
after photoreceptor transplantation (Huang et al., 1998; Woch et
al., 2001), suggesting that despite the partial or complete loss of
photoreceptors, function may be maintained in the inner nuclear
layer and the axons connecting the retina to the brain. Hence,
photoreceptor replacement in the form of a cell-based therapeu-
tic approach might possibly aid in the restoration of some degree
of vision. Embryonic stem cell therapy, although promising, re-
mains highly controversial and must overcome the potential
problem of rejection. In this respect, if an accessible pluripotent
stem cell source can be identified, autologous stem cell therapies
offer a great advantage.
A limited number of retinal stem cells have been successfully
extracted from the pigment ciliary margin (Tropepe et al., 2000)
and differentiated into neurons, such as photoreceptors, in vitro.
Extraction of these cells involves complicated microsurgical pro-
cedures, and the limited availability of pluripotent retinal stem
cells means that this approach is not an option for the treatment
of genetically inherited ocular diseases. In contrast, the bone
marrow is an ideal source of pluripotent stem cells, because it is
the primary site of hematopoietic stem cell renewal and differen-
tiation. It is comprised of at least two types of stem cells: hema-
topoietic stem cells and stem cells for nonhematopoietic tissues,
which commonly referred to as marrow stromal cells (MSCs).
These highly undifferentiated, self-renewing elements were orig-
inally thought to be severely limited in their capacity for differ-
entiation, but recent reports of their differentiation into muscle,
glial, hepatic, renal, and neural lineages has challenged this no-
tion (Eglitis and Mezey, 1997; Ferrari et al., 1998; Petersen et al.,
1999; Kopen et al., 1999). Because of its autologous characteristic,
relative ease of isolation, and its less controversial nature, this
pool of pluripotent stem cells remains a forerunner as the cells of
choice in the treatment of diseases using cell-based therapy.
A number of investigations have shown the multilineage po-
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tential of MSCs into neural lineages (Azizi et al., 1998; Brazelton
et al., 2000; Mezey et al., 2000), which prompted us to attempt
their induction into photoreceptors in vitro and in vivo. For the
first time, we show the ability of adult CD90 MSCs to be in-
duced into cells expressing photoreceptor-specific markers in
vitro using activin A, taurine, and epidermal growth factor (EGF).
In addition, and more significantly, we demonstrate the success-
ful transplantation of adult CD90 MSCs into the adult rat eye
with minimal side effects, the in vivo survival of these cells, their
partial integration and differentiation into the host retina, and
potential functional activity.
Materials and Methods
Reagents.  minimal essential medium (MEM), fetal bovine serum
(FBS), normal rabbit serum, penicillin G, streptomycin sulfate, trypsin-
EDTA, L-glutamine, transforming growth factor 1 (TGF1), murine
natural EGF, and TRIzol reagent were purchased from Invitrogen (Mel-
bourne, Australia). Insulin, 5,8,11,14-eicosatetraynoic acid, dexametha-
sone, bovine serum albumin (BSA), activin A, and taurine were obtained
from Sigma (St Louis, MO). PharMingen (San Diego, CA) supplied all
primary antibodies and the streptavidin-allophycocyanin conjugate
(Sav-APC), with the exception of anti-opsin and anti-collagen type II and
all secondary antibodies mentioned, which were obtained from Sigma.
The recoverin antibody was purchased from ProteinTech Group (Chica-
go, IL). Triton X-100 was supplied by BDH Chemicals (Victoria, Austra-
lia). All tissue culture plasticware was obtained from Becton Dickinson
(Franklin Lakes, NJ).
Isolation and culture of MSCs. The primary culture of rat MSCs was
performed using standard techniques described previously (Phinney et
al., 1999; Woodbury et al., 2000), in accordance with the policy of The
Society of Neuroscience for animal use in experimentation.
Stromal cell characterization and purification. The CD90 MSCs were
analyzed using fluorescent-activated cell sorting (FACS) (FACSCalibur;
Becton Dickinson). In brief, harvested cells were fixed with 70% metha-
nol, washed in PBS, and incubated for 1 hr on ice with fluorescent-
conjugated monoclonal antibodies (1:100 dilution) directed against the
following cell surface markers: CD11b, CD45, and CD90. After washing,
secondary antibody (SAv-APC; 1:100 dilution) was added, and the cells
were incubated on ice for 1 hr. Cells were washed an additional two times
before analysis. For purification, the cells were sorted using a FACSVan-
tage cell sorter (Becton Dickinson) after the fluorescence-labeling proce-
dure mentioned above, with the exception that the cells were not fixed
before analysis. MSCs solely expressing CD90 were then aseptically col-
lected, recultured, and used in all subsequent experiments.
Multipotency of CD90 MSCs. Adipogenic differentiation was per-
formed using a method described previously (Kopen et al., 1999), and the
cells were stained with Oil Red O and Sudan Black B. Chondrogenic
differentiation was performed using a modified method of Muraglia et al.
(2000), in which CD90 cells were cultured in MEM and TGF1 (10
ng/ml) for 8 –10 d. Cells were then fixed and stained for type II collagen
expression.
Photoreceptor induction in vitro. After 24 hr in culture, basal medium
for CD90 cells was replaced with MEM supplemented with FBS (1%
v/v), penicillin (100 U/ml), streptomycin (100 g/ml), and one of the
following inducing agents: activin A (100 ng/ml), taurine (50 M), or
EGF (100 ng/ml). Cells were cultured for an additional 8 –10 d, fixed, and
then immunocytochemically analyzed.
Immunocytochemistry. CD90 MSCs were fixed, washed, and then
blocked in 5% (w/v) BSA, 10% FBS (v/v), and 0.1% (v/v) Triton X-100 in
1 PBS for 1 hr at room temperature. Cells were incubated with various
primary antibodies for 24 hr at 4°C followed by secondary antibodies
(FITC–tetramethylrhodamine isothiocyanate-conjugated or Streptavi-
din biotin) for a similar period. The antibody complex was visualized
using a fluorescent microscope (Olympus Optical, Tokyo, Japan). Pri-
mary antibodies included the following: microtubule-associated protein
2 (MAP2; 1:500), glial fibrillary acid protein (GFAP; 1:500), rhodopsin
(RHOS; 1:100), protein kinase C (PKC; 1:100), cellular retinoic acid-
binding protein-1 (CRABP1; 1:100), and nestin (1:1000).
Western blot analysis. CD90 MSCs incubated with each inducing
agent over a 10 d period were collected and lysed, and40g of cellular
protein as well as rat retinal tissue (positive control) was electrophoresed
on a 12% (w/v) SDS-polyacrylamide gel. Separated proteins were trans-
ferred electropheretically onto a nitrocellulose membrane (100 mA; 1 hr;
4°C) and immunoblotted using photoreceptor-specific antibodies. In
brief, membranes were blocked for 1 hr at room temperature with 5%
(w/v) skim milk powder in PBS and 0.05% (v/v) Tween 20. After wash-
ing, membranes were incubated at room temperature with primary an-
tibodies [recoverin, 1:100 diluted in 5% (w/v) skim milk powder in PBS;
opsin, 1:500 diluted in PBS] for 1 hr and then washed three times at 10
min intervals. The membranes were then incubated with 1:20,000 dilu-
tion of the secondary anti-rabbit IgG and anti-mouse IgG horseradish
peroxidase-linked antibodies for recoverin and opsin, respectively, for 1
hr at room temperature and then washed for another 30 min. Opsin and
recoverin expression was then visualized using the ECL and ECL Plus
Western blotting detection systems, respectively (Amersham Bio-
sciences, Buckinghamshire, UK).
Semiquantitative reverse transcriptase PCR of the genes for differentia-
tion markers of multilineages. Total RNA was extracted from the cells
using TRIzol reagent and was enriched for mRNA using the RNeasy mini
columns (Qiagen, Hilden, Germany) following the instructions of the
manufacturer. Primers were designed for the following genes:
glyceraldehydes-3-phosphate dehydrogenase (GAPD) (GenBank acces-
sion number AF106860) 5(301–321), 3(561–542); PCNA ( proliferating
cell nuclear antigen) (GenBank accession number NM 022381) 5(163–
182), 3(1116 –1094); recoverin (GenBank accession number D12573)
5(429 – 449), 3(1440 –1420); peripherin (GenBank accession number
AF031878) 5(671– 691), 3(1540 –1520); opsin (GenBank accession
number U22180) 5(73–93), 3(504 – 485); lipoprotein lipase (GenBank
accession number L03294) 5(2811–2831), 3(3468 –3448); and collagen
type II (GenBank accession number L48440) 5(3509 –3527), 3(3982–
3962). The cDNA was synthesized and amplified using the OneStep re-
verse transcriptase (RT)-PCR kit (Qiagen) under the following condi-
tions: reverse transcription at 50°C for 30 min, initial PCR activation at
95°C for 15 min followed by 35 cycles of denaturation at 94°C for 1 min,
annealing at 56 – 62°C for 1 min, and extension at 72°C for 1 min. A final
extension step at 72°C for 10 min was included before samples were being
cooled to 4°C. The RT-PCR samples were then separated by 1.6% agarose
gel electrophoresis and photographed.
In vivo transplantation of CD90 MSCs. A total of 28 Royal College of
Surgeons (RCS) rats were subretinally injected with stem cells using a
modified method of Shen and Rakoczy (2001). Between 50 and 100,000
CD90 MSCs prelabeled with either bromodeoxyuridine (BrdU; 5 M)
or recombinant adeno-associated virus expressing green fluorescent pro-
tein (rAAV.GFP) in 2 l of PBS were injected into the left eye while the
other eye (control) was injected with 2l of PBS. Eyes were monitored up
to 12 weeks after transplantation by fundus color photography and an-
giography. Enucleated eyes were then frozen in optimal cutting temper-
ature compound, sectioned, and then stained for BrdU (1:50), rhodopsin
(1:100), synaptophysin (1:200), and PCNA (1:250) using the methods
described above. Control sections were counterstained to observe nuclei.
For electron microscopic examination, animals were killed under halo-
thane anesthetic and eyes were carefully removed and placed into a fixa-
tive solution containing 4% paraformaldehyde and 0.5% glutaraldehyde
in 0.05 M cacodylate buffer, pH 7.4. The eyes were then trimmed and
reimmersed into a fresh solution of the same fixative for an additional 24
hr. After postfixing in 1% osmium tetroxide, the tissues were then pro-
cessed for transmission electron microscopy (TEM) by conventional
methods and embedded in Araldite. Semithin sections (1m thick) were
stained with 0.5% toluidine blue in 5% borax and examined with a Zeiss
(Thornwood, NY) light microscope. Immunohistochemical analysis us-
ing BrdU was used to identify transplanted cells. Staining revealed that a
majority of transplanted cells was found at the injection site or at the
proximal end of the outer nuclear layer (ON) (data not shown). These
sections, in which transplanted cells predominated, were then carefully
trimmed under a dissecting microscope, and thin sections (70nm thick)
were prepared using an LKB–Wallac (Gaithersburg, MD) Nova ultrami-
crotome. The sections were stained with Reynold’s lead citrate and ex-
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amined in a Philips (Einhoven, The Netherlands) 410LS TEM at an ac-
celerating voltage of 80 kV.
Transduction of CD90MSCs. CD90MSCs were transduced with an
rAAV.GFP in MEM using the method of Lai et al. (2001).
Results
Stromal cell characterization
With the aim of producing a more unified cell population, pri-
mary cultures of MSCs obtained from normal adult RCS-
rdy-p rats were passaged once before analysis by fluorescent
flow cytometry. We analyzed three individually prepared samples
of MSCs and found all cells to be negative for CD45, the cell
surface marker for the leukocyte cell lineage (Fig. 1A, Table 1). In
addition, a small proportion of the population (2.4 –5.8%) was
found to express CD11b, the standard cell surface marker for the
erythrocyte lineage (Fig. 1B, Table 1). In contrast,84% of first-
passage MSCs expressed CD90 (Fig. 1C, Table 1), the undifferen-
tiated cell marker. This population profile changed markedly
with continual passage (Table 1). MSCs of early passage primarily
expressed CD90 (80%), which decreased with subsequent pas-
sages to20% (Table 1). However, a statistically significant de-
crease ( p 0.001) in the number of CD90 cells only occurred
after eight passages, indicating that an accessible source of undif-
ferentiated cells exists in early passage MSCs.
In vitro photoreceptor differentiation
The plasticity of CD90 MSCs was confirmed by initiating their
differentiation into adipogenic and chondrogenic cell lineages.
This was confirmed by RT-PCR, demonstrating the expressions
of lipopolylipase and type II collagen, respectively (data not
shown).
The potential of CD90 MSCs to differentiate into any of the
retinal cell lineages was assessed by exposing them to the follow-
ing specific inducing agents: taurine, activin A, and EGF. After
induction with taurine, activin A, and EGF, 30% of the cell
population expressed RHOS, a photoreceptor-specific cell
marker (Figs. 2B--D, 3A). Similarly, 30% of the CD90 MSCs
stained positively for CRABP1, an amacrine cell marker (Figs.
2G--I, 3A). All three agents also induced a small number of
CD90MSCs (6 –10%) to express nestin, a typical neural stem
cell marker (Figs. 2L--N, 3A). Untreated control CD90 MSCs
did not stain against any of the markers tested (Fig. 2E, J,O). In
addition, none of the treated MSCs showed positive staining with
the monoclonal antibody to PKC, which specifically identifies
bipolar cells in the retina, astrocytic marker GFAP, or MAP2, a
neural cell marker (data not shown).
Photoreceptor-specific differentiation was also confirmed us-
ing Western blot analysis and RT-PCR. Incubation of CD90
MSCs with activin A, taurine, or EGF (Fig. 3B, lanes 3–5, C,D,
lanes 2– 4, respectively) all resulted in the expression of the
photoreceptor-specific encoders opsin (Fig. 3B,C) and recoverin
(Fig. 3B,D). Undifferentiated control CD90MSCs incubated in
a basal medium did not express any of these markers (Fig. 3B,
lane 2, C,D, lane 5). CD90 MSCs incubated in the same induc-
ing agents (Fig. 3E, lanes 6 – 8) as well as undifferentiated controls
(Fig. 3E, lane 9) were all found to express the proliferation marker
PCNA. Equal loading of samples was confirmed by the expres-
sion of GAPD (Fig. 3E, lanes 2–5).
In vivo photoreceptor differentiation
Having established that CD90MSCs could be driven to express
photoreceptor lineage-specific markers in vitro, we examined the
influence of the ocular microenvironment on the fate of these
cells. Subretinal injection of both PBS and a single-cell suspen-
sion of uninduced CD90 MSCs into 4 –5-week-old recipient
animals resulted in the formation of a subretinal bleb covering
approximately one-third of the entire retina (Fig. 4A,B). The
injected subretinal fluid was almost entirely absorbed by day 4
after injection (data not shown). Color fundus photography be-
tween 1 and 5 weeks after injection revealed no teratoma forma-
tion in the recipient retina (Fig. 4C,E). Immunohistochemical
analysis also confirmed the nonproliferating nature of trans-
planted CD90 MSCs by the lack of staining for the cell prolif-
Figure 1. A–C, Forward and side scatter plots of CD45 ( A), CD11b ( B), and CD90 ( C) cells
showing the characterization of undifferentiated rat MSCs. Population profiles of first-passage
MSCs were found to primarily express CD90 (84 3.8%).
Table 1. The effect of passage on MSC differentiation
Passage number CD45 (%) CD11b (%) CD90 (%)
1  4.15 1.7 84 3.8
4  2.11 0.83 80.3 4.4
8  1.98 0.57 68.92 6.1
12  1.25 0.24 66.45 7.8
15  0.61 0.02 41.75 6.2
20  0.83 0.2 42.22 5.9
23  0.1 0.01 17.5 5.5
The percentage of MSCs expressing CD90 remains constant up to passage four but significantly decreases (p
0.001) by the eighth passage.
7744 • J. Neurosci., August 27, 2003 • 23(21):7742–7749 Kicic et al. •Marrow Stromal Cell Differentiation into Photoreceptors
eration marker PCNA (data not shown). The delivered MSCs
were quite evenly distributed in the injected area, but cell clumps
were occasionally observed (Fig. 4E, arrows). The injected
CD90 MSCs were unable to migrate outside the perimeter of
the retinal bleb created initially (Fig.
4C,E). No neovascularization, leakage, or
other vascular changes were observed after
CD90MSC transplantation (Fig. 4G,H).
Immunohistochemistry of retinas con-
taining transplanted BrdU-labeled (Fig.
5A) CD90 MSCs confirmed that the
transplanted cells were distributed around
the injection site and remained present up
to 12 weeks (duration of observation) (Fig.
5B--E). Subretinal injection of MSCs re-
sulted only in a slight disruption to the cel-
lular architecture in the host retinas (Fig.
5B,C,E), which was localized primarily at
the site of injection. Within the original
bleb, little or no disruption to host retinas
was observed at sites distant to the injec-
tion site (Fig. 5D). There was also a sub-
stantial migration of BrdU-labeled cells
across the retina within a short period of
time. Within 2 weeks after injection, a
number of CD90 MSCs moved across
the photoreceptor outer and inner segment layers and incorpo-
rated into the ON among the nuclei of photoreceptors in the area
defined by the bleb (Fig. 5G). The presence of BrdU-labeled cells
in the ON was also confirmed at 12 weeks after injection, al-
though signal intensity was weaker (Fig. 5I). There were no
BrdU-labeled cells found in areas distant to the injection site (Fig.
5F,H). These results demonstrated that CD90 MSCs not only
integrated into the retina but also remained there for an extended
period of time, providing an opportunity for these cells to differ-
entiate into neural retinal cells.
At all time points, the majority of the integrated BrdU-labeled
cells was found in the ON (Fig. 5J). Mature photoreceptors have
a unique structure comprising of stacks of photoreceptor nuclei
forming the outer nuclear layer and an elongated cytoplasm
forming the photoreceptor inner and outer segments (Besharse
and Pfenninger, 1980). Opsin, the protein forming the visual
pigment, is normally present in the photoreceptor inner and
outer segments but is not detectable in the outer nuclear layer
(Fig. 5K). Eyes injected with CD90MSCs show the typical outer
segment staining of opsin in undisrupted retinas distant to the
injection site (Fig. 5L). However, the vast majority of cells located
at the injection site demonstrated typical RHOS antibody stain-
ing in their cytoplasm (Fig. 5M,N), which paralleled observa-
tions made in vehicle-injected control animals (data not shown).
Additional investigation demonstrated that a number of the cells
that were immunoreactive for the RHOS antibody within their
cytoplasm were also positive for BrdU (Fig. 5O, bottom arrows)
and could be distinguished easily from endogenous photorecep-
tors, the opsin expression of which had been translocated to their
cytoplasm caused by the retinal detachment resulting from the
injection procedure (Fig. 5O, top arrow). It was interesting to
note that whereas BrdU demonstrated nuclear localization,
RHOS staining was cytoplasmic surrounding the green nuclei
(Fig. 5O, inset). However, even at 12 weeks after injection, the
morphology of the double-labeled cells remained circular, and
there were no morphological changes suggesting outer segment
development. Considering the localization of these cells in the
ON and that opsin is exclusively expressed by photoreceptors, it
is proposed that RHOS immunoreactivity present in the ON
demonstrates the presence of immature photoreceptors.
One of the most important prerequisites for the development of
Figure 2. A, F, K, Phase contrast micrographs of CD90MSCs induced by activin A. Fluorescent micrographs of immunocyto-
chemical analysis of CD90MSCs induced by activin A ( B, G, L), taurine (C, H, M ), and EGF ( D, I, N ), using photoreceptor (RHOS)
( B–E), amacrine (CRABP1) ( G–J), and neural (nestin) ( L–O) specific antibodies, are shown. Uninduced CD90MSCs cells did not
stain for any markers tested ( E, J, O). Magnification, 400.
Figure 3. A, Quantification of CD90 cell differentiation after induction with activin A tau-
rine or EGF using RHOS (photoreceptor), CRABP1 (amacrine), and nestin (neural)-specific mark-
ers, respectively. B, Western blot analysis of induced CD90MSCs. Note that rat retinal tissue
(lane 1), undifferentiated CD90 MSCs (lane 2), activin A (lane 3), taurine (lane 4), and EGF
(lane 5) are shown. C, D, RT-PCR of opsin ( C) and recoverin ( D). Note that, in C–E, activin A (lanes
2, 6), taurine (lanes 3, 7), EGF (lanes 4, 8), and undifferentiated CD90 cells (lanes 5, 9) are
shown. C, D, Undifferentiated CD90 cells were found to not express any of these markers (lane
5). E, GAPD expression (lanes 2–5) and proliferating marker PCNA expression (lanes 6 –9).
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a functional photoreceptor layer is the ability of the transplanted cells
to establish neuronal connections. Synaptophysin, a synaptic vesicle
protein involved in neuronal transmission (Weidmann and Franke,
1985), is typically observed in the outer plexiform and ganglion lay-
ers of normal retina (Fig. 5P). Immunohistochemical studies re-
vealed that the BrdU-positive cells in CD90 MSC-injected eyes
colocalized within areas that were immunoreactive for synaptophy-
sin (Fig. 5Q). Because a majority of BrdU-labeled cells was observed
primarily at the proximal end of the outer nuclear layer by 5 weeks
after transplantation (Fig. 5R), closer inspection of these sites via
electron microscopy demonstrated the presence of synaptic vesicles
surrounding transplanted cells (Fig. 5S).
Transduction of MSCs
To avoid rejection related to allogeneic transplantation, we pro-
pose autologous heterotopic transplantation using the recipients’
own MSCs. The genetic abnormality responsible for the develop-
ment of retinal dystrophy or degeneration will therefore still be
present in the MSCs. To investigate the potential of combining
gene and stem cell therapies, we used a rAAV.GFP to transduce
solely expressing CD90MSCs. In our hands,5–7% of CD90
MSCs were successfully transduced (Fig. 6A,B). GFP cells were
sorted and expanded once for subsequent in vivo experiments. At
3 weeks after injection, examination of whole-mounted retinas
transplanted with rAAV.GFP-transduced CD90 MSCs showed
the presence of GFP cells covering approximately one-third of
the total retina (Fig. 6C). The signal intensity decreased with
increasing distance from the injection site (Fig. 6D) and finally
disappeared beyond the border of the retinal bleb. Histological
assessment of the injection site (Fig. 6E,F) confirmed this finding
with a large proportion of GFP cells located at the site of injec-
tion (Fig. 6E, arrows) within the ON (Fig. 6F, arrows).
Discussion
Embryonic stem cell therapies may hold enormous potential for
the treatment of a wide range of degenerative diseases. However,
this approach remains highly controversial, and in many coun-
tries, legislation has been introduced to limit their derivation and
use (Vogel, 2000). In addition, the problem of rejection still needs
to be resolved. This has been highlighted by a recent study by
Drukker and colleagues (2002), which has shown that human
embryonic stem cell major histocompatibility complex class I
expression moderately increases with in vitro and in vivo differ-
entiation, suggesting that these cells may be rejected during trans-
plantation. In this respect, the identification of an easily available
stem cell source would offer the advantage of autologous stem cell
therapies. Results of recent investigations (Azizi et al., 1998; Bra-
zelton et al., 2000; Mezey et al., 2000) have demonstrated the
plasticity of MSCs into neural lineages. This prompted us to at-
tempt their differentiation into photoreceptors for both in vitro,
whereby MSCs were exposed to particular agents described pre-
viously to induce stem cell differentiation into photoreceptors,
and in vivo, whereby MSCs were transplanted into the subretinal
space of normal rats, and cell fate was assessed over 3 months.
A number of previous investigations has demonstrated MSC
plasticity by their differentiation into chondrogenic, adipogenic,
and osteogenic cell lineages (Mackay et al., 1998; Kopen et al.,
1999; Pittenger et al., 1999; Muraglia et al., 2000). This multilin-
ear potential has been highlighted also with several recent studies
showing successful differentiation of MSCs into muscle, glia, ep-
ithelia, and liver cells (Eglitis and Mezey, 1997; Ferrari et al., 1998;
Kopen et al., 1999; Petersen et al., 1999; Orlic et al., 2001; Jiang et
al., 2002).
Preliminary characterization confirmed previous findings
that heterogenous rat MSC populations primarily express CD90
with little or no lymphohematopoietic cell marker expression
(Table 1). Analysis also revealed that these cells expressed very
low or negligible levels of CD11b and CD45, which are typically
expressed by the default cell types for MSCs. Future immuno-
blotting experiments on those cells that did not express any of the
marker tested in this study could then be used to obtain a com-
plete phenotypic profile of MSCs.
A number of previous investigations have demonstrated that
taurine, activin A, and EGF are present in the retina and are
possibly involved in inducing photoreceptor differentiation both
during embryonic development (Lillien and Cepko, 1992; Davis
Figure 4. Ophthalmic examination of CD90 MSC transplanted retinas at different time
intervals. A–H, Fundus photographs ( A–F) and fluorescein angiograms (G, H ) after subretinal
injection of CD90 MSCs. Subretinal injection induced temporary retinal detachment ( A, B,
circled by dotted lines) with the size of one-third of the whole retina. C–F, Distribution of
CD90MSCs at 2 weeks (C, D) and 5 weeks ( E, F ) after injection. Even distribution with some
clumped cells is present (arrows). Note that no teratoma formation was observed up to 5 weeks
after injection. G, H, Fluorescein angiograms of CD90 MSCs ( G) and vehicle (control) ( H )-
injected eyes at 5 weeks after injection. Note that no sign of ocular neovascularization is present.
Asterisks indicate sites of subretinal injection. Solid circles, Artifactual reflex from the modified
clinical fundus camera.
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et al., 2000) and postnatally (Anchan et al., 1991; Altshuler et al.,
1993). It has been observed that embryonically derived retinal
precursors require the presence of EGF to sustain their undiffer-
entiated state and that its primary activity is to promote prolifer-
ation rather than differentiation in vitro
(Ahmad et al., 1998, 1999). However, to
our knowledge, this is the first investiga-
tion to show that these agents are capable
of inducing adult-derived CD90 MSCs
to express photoreceptor-specific markers
in vitro. Having demonstrated their differ-
entiation via specific marker expression by
Western blot analysis and RT-PCR, addi-
tional studies using a more quantitative
approach would be required to see whether
the specific photoreceptor marker expres-
sion patterns observed in this study correlate
to the expression patterns of normal func-
tioning photoreceptors.
Previous studies have shown that bone
marrow-derived stem cells (Tomita et al.,
2002) and neural progenitor cells (Nishida
et al., 2000; Young et al., 2000; Pressmar et
al., 2001) can integrate and differentiate
more readily in diseased retinas than in
healthy retinas. One of the major concerns
of stem cell or pluripotent cell injection is
adverse effects related to uncontrolled cell
proliferation. Considering the potential
applications, it is an important observa-
tion that CD90MSCs can be successfully
injected into animals without any serious
pathological consequences. Our findings
suggest that once in the retinal microenvi-
ronment, CD90 MSCs either undergo
differentiation into potentially function-
ing photoreceptors or remain undifferen-
tiated with little disruption to the host
retinal morphology. Biological complica-
tions like that related to neoplasia seem
unlikely, because color fundus photogra-
phy 12 weeks after transplantation (data
not shown) showed a similar morphology
to that observed at 5 weeks (Fig. 4), and
transplanted cells did not show any immu-
noreactivity to PCNA, a proliferation
marker (data not shown). However, in this
study, the signal intensity of BrdU-labeled
transplanted cells did in fact diminish over
time. This observation may suggest that in
the case of syngenic transplantations, the
long-term survival of transplanted cells in
the retina remains uncertain, which could
be a cause for concern (Zhang and Bok,
1998). Additional studies are required to
investigate this further.
Previously, Chacko et al. (2000) showed
that embryonic retinal progenitor cells
could be transplanted into the subretinal
space of 2-week-old rats, and that at 26 d
after transplantation, injected progenitor
cells had incorporated into the host retina
and expressed opsin and recoverin with-
out disrupting the morphology and lami-
nar organization of the host retina. Work conducted by Kopen et
al. (1999) observed that CD90 MSCs could also be successfully
engrafted into the neonatal brain, which results in their differen-
Figure 5. A–S, CD90 MSC fate 1–12 weeks after transplantation. A, CD90 MSCs were prelabeled with BrdU before
injection (400). B–E, H, Hematoxylin and eosin ( H, E) staining of retinas 7 d after transplantation ( B–D) revealed a large
number of CD90MSCs in the subretinal space at the site of injection (B, arrow) (100), with only slight disruption to the host
retina (C, arrow) (200) occurring at the site of injection. Retina distant to the injection site ( D) (200) revealed normal
structural integrity. E, Retinas 5 weeks after transplantation histologically appeared normal with very little disruption to the host (200).
Pockets of CD90MSCs were observed still in the subretinal space, although these were observed primarily at the site of injection (arrow)
(200). G, I, Detection of BrdU-labeled CD90MSCs in the ON at the site of injection at 7 d ( G) (300) and 5 weeks ( I ) after transplan-
tation (300). F, H, Retina distant to the injection site appeared normal and did not contain any transplanted cells at 7 d ( F) (300) and
5 weeks ( H ) (300) after transplantation. Even 5 weeks after transplantation, CD90 cells were still primarily found within the ON ( J)
(200), adjacent to the injection site of host retinas. K, Expression of the photoreceptor-specific marker opsin revealed typical outer
segment staining in nontransplanted retinas (300). L, A similar pattern of opsin expression in host retina distant to the injection site
(100). M, At the injection site, the outer segment staining becomes less apparent, because the structural hierarchy of the host retina is
not fully restored after transplantation but is primarily expressed in the cytoplasm of cells located within the injection site (100). N,
Higher magnification of the injection site revealed the cytoplasmic expression of opsin in these cells (400). O, Transplanted cells were
identified by the coexpression of BrdU (green) and opsin (red) within the injection site (1000; inset, 2000). Bottom arrows highlight
two injected MSCs that were immunoreactive for BrdU and the RHOS antibodies. The top arrow indicates an endogenous photoreceptor
whose opsin expression had been translocated to its cytoplasm as a result of the injection procedure. P, Synaptophysin expression in
nontransplanted retina typically stains positive (indicated as red) in the outer plexiform and ganglion cell layers (100). Q, Higher
magnification reveals the colocalization of BrdU and synaptophysin in CD90MSC-transplanted retina (1000). R, Immunohistochem-
ical analysis of transplanted retina revealed that the majority of BrdU-labeled cells was located at the proximal end of the ON, adjacent to
the OPL (1000). S, Electron microscopic analysis of these cells revealed synaptic vesicle formation (arrows) (31,200). G, Ganglionic cell
layer; IN, inner nuclear layer; OPL, outer plexiform layer; OS outer segments.
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tiation into astrocytes and neurons without disrupting the sur-
rounding tissue. These observations demonstrated that photore-
ceptors could potentially be produced from embryonic retinal
progenitor cells, and that engrafting into neuronal tissue does not
induce neoplasia. However, the clinical benefits of these observa-
tions for the treatment of retinal degenerative disorders are
somewhat limited because of ethical issues, limited accessibility,
number of retinal progenitor cells, and the potential of tissue
rejection by the host.
Our observation that adult CD90 MSCs injected into the
subretinal space of adult rats can be differentiated into photore-
ceptors with similar efficiency as embryonic retinal progenitor
cells offers a potential treatment strategy for retinal degenerations
and dystrophies. Our in vivo results also correlate well to the
preliminary findings of Tomita and colleagues (2002), who
showed similar levels of integration and differentiation of bone
marrow-derived stem cells when injected into the intravitreous
space of rats whose retinas were mechanically injured. Impor-
tantly, we found that adult autologous heterotopic transplanta-
tion of CD90MSCs recovered from the recipient bone marrow
and corrected for the genetic abnormality are capable of becom-
ing functional photoreceptors, thus restoring dysfunctional reti-
nas in humans. However, this study represents only the first step
in this path, and several questions regarding the ability of the
differentiated MSCs to develop fully functional rod and cone
receptors remain to be answered.
The ultimate aim of this research is to rescue function in the
macula, or more precisely the cone rich foveola, of sufferers of
different retinal diseases. In humans, the macula is responsible
for 80% of the vision that enables us to function with ease in
society. The treatment of human blinding conditions using this
therapeutic approach would then require concentrated func-
tional cell rescue of this small area. Besides the primate, no other
animal model (including the rodent) possesses a macular, and
thus studying the effects of a relevant functional rescue would be
extremely difficult, because most existing biological functional
tests for rodents (ERG, behavioral tests) require rescue in a rela-
tively large retinal surface. However, the experiments described
in this paper are highly relevant because they establish the follow-
ing principles: (1) bone marrow pluripotent cells can be differen-
tiated into photoreceptors and genetically modified to correct the
underlying disease-causing mutation, and (2) transplanted cells
survive without rejection in the retinal space, do not proliferate,
express photoreceptor-specific markers, and are capable of at-
tracting synaptic vesicles. Having established these principles, the
next step would be to conduct primate experiments focusing on
the macula that could then potentially lead to human trials.
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